High-throughput production of polyurethane foam layers

By using mixing, layer formation, conveying and accelerated curing steps in the process of manufacturing the polyurethane foam layer, combined with infrared radiation heating and drying, the problems of low production efficiency and out-of-control curing in the prior art are solved, and high efficiency and controllability are achieved Good foam layer production, suitable for medical applications.

CN113993678BActive Publication Date: 2024-11-12MOLNLYCKE HEALTH CARE AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080045396.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-06-24
Filing Date
2020-06-22
Publication Date
2024-11-12
Estimated Expiration
2040-06-22

AI Technical Summary

Technical Problem

The prior art is difficult to achieve high production in a short time when manufacturing polyurethane foam layers for medical applications, while avoiding uncontrolled curing/crosslinking reactions, and the production line speed is low, affecting efficiency.

Method used

Using a process that includes a mixing step, a layer forming step, a conveying step and an accelerated curing step, ensures high yield and control by infrared radiation heating of the foam layer moving on the substrate and reduces moisture content in the drying step sex.

Benefits of technology

It realizes efficient production of polyurethane foam layers in a shorter time than traditional processes, avoids uncontrolled curing reactions, improves process control and production efficiency, and meets the performance requirements of medical applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113993678B_ABST
    Figure CN113993678B_ABST
Patent Text Reader

Abstract

The present invention relates to an at least partially continuous process for manufacturing polyurethane foam layers suitable for medical applications, in particular wound dressings, at higher throughputs than is generally achievable in the art. The process comprises an accelerated curing step of the PU foam, which is carried out at a stage in the overall curing process where the risk of a runaway reaction is minimized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to an at least partially continuous, high-throughput process for producing polyurethane foam layers suitable for medical applications, in particular wound dressings. The process comprises an accelerated curing step of the polyurethane foam, which is performed at a stage in the overall curing process where the risk of a runaway reaction is minimized. Background Art

[0002] Wound dressings are used to heal and protect wounds. The ability of a wound dressing to absorb and retain wound exudate is crucial to the healing process. The fluid handling capacity of a dressing also influences the frequency of dressing changes, which should be minimized to promote wound healing. In particular, hydrophilic materials are used in wound dressings to absorb and retain wound fluids, particularly hydrophilic foams, such as hydrophilic open-cell polyurethane (PU) foams.

[0003] Processes for producing polyurethane (PU) foams particularly suitable for medical applications are known from the prior art, for example from US Pat. No. 5,254,301, which discloses a continuous process for producing polymer-based foam sheets, particularly isocyanate-terminated polyether foams. This process is typically performed at room temperature, and the layer thickness is adjusted by a foam compression step during the curing process. The fact that this process is performed at room temperature means that the heat required to further activate the curing process originates solely from exothermic reactions. The curing of PU foams, particularly TDI-based foams, is performed at room temperature without increasing the curing rate by applying an external temperature increase, as the curing / crosslinking reaction of these foams can be easily accelerated to uncontrollable levels.

[0004] Another process for making hydrophilic foams is described in US 2019 / 0083675, which discloses a process for making multilayer foams comprising a polyurethane foam matrix. A reactive prepolymer mixture is deposited on a (first) foam layer substrate, and the reaction product is allowed to rise. To adjust the desired final thickness, the foam layer is compressed during the curing step.

[0005] The processes for producing PU foams known in the prior art generally require full batch processing (see, for example, US 2015 / 0011666) and / or relatively large production lines and / or are associated with relatively low line speeds. Relatively low line speeds are generally considered necessary, especially for reactive prepolymer mixtures (such as mixtures containing TDI), because lower line speeds increase the residence time of a given foam section in the production line (e.g., before drying and / or storage), thereby allowing the foam layer to fully (or at least sufficiently) cure. Summary of the Invention

[0006] Based on the prior art and background described above, there is a need in the art to provide a process for manufacturing polyurethane foam that allows for higher foam production throughput, particularly for the production of foam suitable for medical applications, in shorter time intervals than is typically achievable in processes known in the art. Such a process should avoid or minimize at least one of the disadvantages known in the art and should allow for improved process control, particularly avoiding or minimizing "runaway" curing / crosslinking reactions, while still allowing for high throughput processing.

[0007] According to a first aspect of the present invention, these and other objects are achieved by a process for producing a polyurethane foam layer, wherein the process comprises at least the following steps:

[0008] (i) at least one mixing step, wherein one or more polyurethane prepolymers or precursors thereof are mixed or contacted with each other and / or with another component in a mixing zone or contact zone;

[0009] (ii) at least one layer-forming step, in which the mixture from step (i) is applied in a layer to a moving substrate and the curing process is initiated on the substrate;

[0010] (iii) at least one conveying step, in which the foamed layer on the substrate from step (ii) is at least partially moved along the production line, in which step the polyurethane prepolymer or its precursor in the foamed layer is at least partially cured and the thickness of the layer increases due to foaming, i.e. due to at least one chemical reaction taking place in the layer;

[0011] (iv) at least one accelerated curing step, which takes place at a predetermined point in time after the end of step (ii), or, respectively, at a predetermined position along the production line, wherein curing is accelerated by subjecting the foam moving on the substrate to radiant heating, preferably infrared radiation.

[0012] In an embodiment of the present invention, the process comprises the following additional steps, which are performed after step (iv):

[0013] (v) separate from and subsequent to step (iv): at least one drying step during which the substantially cured wet foam from step (iv) is dried to a predetermined lower moisture content.

[0014] In a preferred embodiment, the substantially cured wet foam comprises at least 10% w / w water, preferably at least 30% w / w water, further preferably at least 50% w / w water, and is dried to a predetermined moisture content of equal to or less than 10% w / w, preferably less than 5% w / w, further preferably less than 2% w / w.

[0015] Prepolymer of step (i)

[0016] In the mixing or contacting step (i), one or more prepolymers or their precursors may be mixed with themselves or with other components. The other components may in particular be a solvent, in particular a protic solvent, further in particular water. The other components may also or additionally be another precursor or polymer.

[0017] Also included are the mixing of two or more components, in particular precursors that make up a prepolymer or precursors that are mixed together quickly in a so-called "one-shot process".

[0018] In an embodiment of the present invention, the mixing or contacting step (i) is or comprises a step of mixing at least one prepolymer with water.

[0019] There are no restrictions on the prepolymer, precursor, or any other components added, or on the overall mixture used in step (i), so long as the mixture produces a polyurethane foam suitable for use in medical dressings.

[0020] According to the present invention, the term "prepolymer" is understood as defined in the IUPAC: Compendium of Chemical Terminology, 2nd Edition ("Gold Book"), compiled by A.D. McNaught and A. Wilkinson. Blackwell Scientific Publications, Oxford (1997), ISBN 0-9678550-9-8, and generally refers to a polymer or oligomer whose molecules are capable of entering into further polymerization via reactive groups, thereby contributing one or more structural units to at least one type of chain of the final polymer.

[0021] In embodiments of the present invention, the prepolymer may comprise or be an isocyanate-terminated polyol or an isocyanate-terminated polyurethane.

[0022] In an embodiment of the present invention, the prepolymer is derived from the reaction between a polyol and a diisocyanate compound, wherein the diisocyanate compound is selected from hexamethylene diisocyanate (HDI), toluene diisocyanate (TDI), methylene diphenyl diisocyanate (MDI) or isophorone diisocyanate (IPDI) or any mixture thereof.

[0023] Toluene diisocyanate (TDI) or mixtures containing TDI are often preferred for use in medical dressings due to their improved performance as hydrophilic polyurethane foams.

[0024] Other compounds of the mixture of step (i):

[0025] There is no restriction on the presence of other compounds or components in the prepolymer or precursor mixture of step (i), as long as these other compounds or components do not render the resulting PU foam unsuitable for medical applications, in particular wound care applications.

[0026] Suitable components to be included in the mixture of step (i) are, for example, water (used as solvent and / or "chemical" blowing agent), surfactants (wetting agents), catalysts, solvents (other than water), blowing agents, chain extenders, hydrophilizing agents, crosslinking agents, pigments, filler particles, auxiliaries, additional polymer components, etc.

[0027] In an embodiment of the present invention, the mixture further comprises at least one surfactant, preferably a nonionic surfactant.

[0028] Step (ii): "Base" and start of curing

[0029] The curing of a given prepolymer or precursor mixture, for example by a chemical reaction between the OH groups of a polyol and the isocyanate groups of a polyisocyanate, or by a chemical reaction between water and isocyanate groups (for example, in a step of producing an aqueous prepolymer-containing mixture, which step comprises the step of mixing a prepolymer composition containing a prepolymer with water) will generally begin from the moment at which the at least two component mixtures come into contact with one another, i.e. already in step (i), or even earlier. However, for the purposes of the timing of the curing process according to the present invention, the "start" of the curing process is defined as the moment at which a given volume of the prepolymer or precursor mixture from step (i) is applied to the moving substrate in step (ii).

[0030] The term "curing" as used in accordance with the present invention particularly includes the formation of bonds between the polymers of the prepolymers in the mixture, in particular crosslinking bonds are or include urethane bonds formed by reaction between hydroxyl groups on the first polymer and isocyanate (NCO) groups on the second polymer, or urea bonds formed by reaction between amine groups on the first polymer and isocyanate (NCO) groups on the second polymer.

[0031] According to the present invention, the term "curing" includes "cross-linking", ie cross-linking is one aspect, preferably the main effect of the entire curing process.

[0032] The term "crosslinked" is used herein to describe a material comprising a plurality of polymer molecules that are interconnected by chemical bonds, in particular covalent or ionic bonds, or by physical crosslinks.

[0033] In an embodiment of the present invention, the prepolymer or precursor from step (i) is applied to a moving substrate in a mixed or aggregated manner to produce a given "coating weight" on the substrate ("coating weight" = grams of the mixture dispensed per square centimeter of substrate). The coating weight is suitable for producing the desired final foam layer thickness. In an embodiment of the present invention, the grammage is 30 g / m 2 Up to 1000g / m 2 , preferably 50g / m 2 Up to 500g / m 2 , further preferably 75g / m 2 Up to 250g / m 2 These grammages generally correspond to film thicknesses which are reasonably transparent to radiation, in particular IR radiation, as used in step (iv).

[0034] As used herein, the term "layer" should be understood as having a continuous extension in one plane (x and y directions) and a thickness perpendicular to said plane (z direction). According to the invention, the length of the final foam layer produced (usually a rolled batch of dried and cured layers ready for storage) is at least an order of magnitude greater than the width of the layer. The width of the layer is at least 5 times greater than the thickness of the layer.

[0035] No restrictions apply to the specific implementation of the moving substrate, as long as the substrate is capable of receiving the prepolymer or precursor mixture from step (i) without substantially reacting therewith (i.e., being substantially inert with respect to the prepolymer / precursor mixture), and is capable of conveying a given volume segment of the prepolymer mixture along at least a portion of the overall production line as the prepolymer mixture solidifies (i.e., transferring it in at least one direction), and ultimately allowing the removal of the (substantially) solidified polyurethane foam or the solidified and dried polyurethane foam.

[0036] In an embodiment of the invention, the substrate is realized as a moving conveyor belt, preferably as a moving web.

[0037] In other embodiments of the invention, the substrate is implemented as a removable release liner which is subsequently removed ("sacrificial layer"). Suitable materials are silicone-coated or fluoropolymer-coated release liners. Silicone-coated liners are preferred.

[0038] Furthermore, there is no restriction on how the mixture of step (i) is applied to the substrate. Preferably, it is applied via a nozzle. More preferably, the nozzle is configured as a slit that defines the initial width and initial thickness of the layer present on the substrate.

[0039] In an embodiment of the present invention, the foam layer applied to the substrate, ie the foam layer at the start of step (ii), has an initial thickness of 100 μm to 8 mm, preferably 250 μm to 2 mm.

[0040] Delivery step (iii)

[0041] In an embodiment of the present invention, in the conveying step (iii), a given volume segment of foam is linearly conveyed for at least 3 m, preferably not less than 10 m, further preferably not less than 20 m. A further preferred range is 20 m to 80 m or 30 m to 50 m.

[0042] In an embodiment of the present invention, in the conveying step (iii), a given volume segment of foam is conveyed for 36 seconds to 900 seconds, preferably 180 seconds to 320 seconds.

[0043] Accelerated curing step (iv)

[0044] In an embodiment of the present invention, the "predetermined point" in time of step (iv) at which a given volumetric section of the conveyed foam layer is subjected to radiant heating may be determined by the thickness of the layer, the degree of cure or any other suitable parameter, in particular the temperature. The reference point for measuring any of these predetermined points is the start of step (ii), i.e. the point along the production line at which the prepolymers or precursors from step (i) are mixed or brought together and applied to the moving substrate.

[0045] In an embodiment of the invention, said "predetermined point" in time in step (iv) is reached when the thickness of the foam has increased by at least 60%, preferably at least 80%, relative to the thickness of the layer initially applied in step (ii).

[0046] In an embodiment of the invention, said "predetermined point" in time in step (iv) is reached when the peak temperature of foam curing has been reached, preferably when the peak temperature has passed, ie the temperature has dropped or started to drop from a maximum value.

[0047] According to the present invention, the "peak temperature" is the highest or maximum temperature measured at the surface of the foam at a predetermined point in step (iii). Said temperature is suitably measured using an infrared temperature sensor.

[0048] In an embodiment of the present invention, said "predetermined point" in time in step (iv) is reached when the temperature of the foam layer is in the range of 25°C to 35°C, preferably 27°C to 32°C, after the temperature is in the range of 18°C ​​to 24°C, preferably 18°C ​​to 23°C at the start of step (iii).

[0049] In an embodiment of the present invention, said "predetermined point" in time in step (iv) is reached 2 to 10 minutes after the start of step (iii), preferably 3 to 7 minutes after the start of step (iii).

[0050] In an embodiment of the invention, said "predetermined point" in time in step (iv) is reached once a given volumetric section of the foam layer has reached a degree of cure of 50% to 90%, preferably 65% ​​to 85%.

[0051] As used herein, the term "degree of cure" refers to the percentage of isocyanate groups that have reacted as measured by Fourier transform infrared spectroscopy (FTIR), i.e., a degree of cure of 100% means that substantially all isocyanate (NCO) groups have reacted, while a degree of cure of 0% means that substantially no isocyanate (NCO) groups have reacted.

[0052] The amount of NCO groups and, accordingly, the degree of cure, can be monitored in situ (i.e., along the production line, for example, by FTIR) at different stages of the process for producing the composite material. The number of NCO groups corresponding to 0% degree of cure can be measured, i.e., a calibration can be performed before the prepolymer / precursor components are mixed, in particular before mixing with water, i.e., before step (i).

[0053] As used in accordance with the present invention, the terms "fully cured" and "substantially fully cured" refer to a degree of cure of 90-100%.

[0054] Without wishing to be bound by theory, the applicant believes that during the entire curing process in which the accelerated curing step (iv) is carried out, the curing / crosslinking reaction is already significantly weakened and that curing can be advantageously accelerated by means of a uniform energy input, i.e. energy input via radiation, in particular via IR radiation. By selecting a uniform acceleration produced by the radiation input and by selecting a time point after which the majority of the curing has already occurred, the risk of a "runaway" curing reaction that could occur in the early stages of the overall curing process is minimized or avoided altogether.

[0055] In an embodiment of the invention, the "predetermined position" along the production line in step (iv) is 5 m or more, preferably 10 m or more, further preferably 20 m or more, from the point in the production line where the mixture from step (i) is applied to the substrate (i.e. "downstream").

[0056] In an embodiment of the invention, said "predetermined position" along the production line in step (iv) is in the downstream half of the production line [i.e. further down the production line from the point where the mixture from step (i) is applied to the substrate], preferably in the last third of the production line.

[0057] In an embodiment of the present invention, the maximum temperature reached on the surface of the foam layer by the accelerated curing of step (iv) is controlled in the range of 30°C to 95°C, preferably 45°C to 90°C.

[0058] In an embodiment of the present invention, the area of ​​accelerated curing, ie the area of ​​step (iv), extends within the range of 1 m to 10 m, preferably within the range of 2 m to 6 m of the entire production line.

[0059] In an embodiment of the present invention, accelerated curing is achieved by providing at least 2 IR lamps along the production line and towards the moving foam layer, preferably by at least 4 IR lamps, further preferably by at least 6 IR lamps.

[0060] Without wishing to be bound by theory, the applicant believes that heating by radiation, in particular UV heating (in the wavelength range of 100 nm to 350 nm), IR heating (in the wavelength range of 700 nm to 1 mm) or microwave heating (in the wavelength range of 1 mm to 300 mm) is particularly advantageous for accelerating the chemical reaction during the curing process of the foam layer, because such radiation is able to at least partially penetrate the foam layer and then be absorbed by the interior of the foam layer, thereby accelerating the chemical reaction by increasing the temperature not only from the outside, but also from the inside.

[0061] In contrast, conventional heating by convection or conduction, as achieved through conventional heating methods, such as in an oven, exposes the foam layer to hot air, which primarily increases the temperature from the outside and results in temperature gradients. Introducing such temperature gradients during the overall curing process, where curing has weakened but not yet stopped or has essentially stopped, can result in curing gradients across the width and length of the layer (more on the outside than on the inside), which can ultimately lead to a non-uniformly cured foam layer. Furthermore, conventional heating heats not only the foam but also the surrounding area, requiring thermal management.

[0062] Thus, according to the present invention, radiant heating allows the entire curing process to be accelerated while minimizing the gradient of the degree of cure along the thickness or width of the foam layer. Radiant heating also allows for increased response time relative to convection heating / hot air heating / oven heating.

[0063] These advantages of radiation acceleration are particularly applicable to polyurethane-based foams, as these are characterized by relatively poor thermal conductivity.

[0064] In a preferred embodiment of the present invention, the accelerated curing of step (iv) is achieved by infrared heating using two or more, preferably four or more, IR lamps, more preferably four to ten IR lamps. In a further embodiment, the lamps are spaced 20 cm to 2 m apart, preferably 40 cm to 100 cm apart. The inventors have found that by spacing the lamps too close together, in particular by spacing the lamps within the aforementioned distances, overheating of the curing foam can be avoided or minimized.

[0065] (v) Drying step

[0066] In an embodiment of the present invention, after step (iv), the process comprises a further separate drying step (v).

[0067] In contrast to step (iv), the purpose of the drying step is not primarily to accelerate curing ("post-curing" may still occur during the drying step), but rather to reduce the water content in the foam layer.

[0068] In an embodiment of the invention, the foam has cured to an extent of at least 90%, preferably at least 95%, prior to the drying step (v).

[0069] In a preferred embodiment, the substantially cured wet foam comprises at least 10% w / w water, preferably at least 30% w / w water, further preferably at least 50% w / w water, and is dried to a predetermined moisture content of equal to or less than 10% w / w, preferably less than 5% w / w, further preferably less than 2% w / w.

[0070] For foams used in medical applications, a residual water content of, for example, 5% w / w is generally considered to be beneficial for foam performance.

[0071] In an embodiment of the present invention, the temperature (maximum temperature or average temperature, or both) in the drying step (v) is lower than the temperature in the accelerated curing step (iv).

[0072] In an embodiment of the invention, in step (v) conventional heating by convection and / or conduction is used as the primary source of thermal energy and no additional energy input is provided by radiation.

[0073] In an embodiment of the present invention, the maximum temperature reached by drying in step (v) is in the range of 25°C to 120°C, preferably 50°C to 75°C.

[0074] According to a second aspect of the present invention, the above and other objects are achieved by providing a wound dressing comprising a foam obtained or obtainable by a process according to the present invention.

[0075] In an embodiment of the invention, the wound dressing comprises said foam layer, wherein said wound dressing further comprises at least one additional layer, preferably a backing layer and / or an adhesive layer or a coating, preferably two or more of these additional layers.

[0076] General Definition

[0077] In the claims, the terms "comprising" and "comprise(s)" do not exclude other elements or steps, and the indefinite article "a" or "an" does not exclude a plurality of elements or steps.

[0078] The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage. BRIEF DESCRIPTION OF THE DRAWINGS

[0079] The above and other aspects of the present invention will now be described in more detail with reference to the accompanying drawings which show exemplary embodiments of the invention, in which:

[0080] Figure 1 A schematic and exemplary sketch of the entire production line (1) is shown, comprising a mixing chamber (10), here exemplarily shown three feed lines (11), a device for applying the foam layer, here exemplarily implemented as a nozzle (12), a substrate (20), here implemented as a moving conveyor belt, from which the foam layer (21) is dispensed onto the substrate, covered with an optional protective layer (22), an area for accelerating curing (30), here exemplarily equipped with three IR lamps (31), and a heating area (40) for drying the foam.

[0081] Figure 2 shows an exemplary wound dressing using a solidified polyurethane foam (21') manufactured according to the process of the present invention, the wound dressing comprising a backing layer (23), the solidified foam layer (21') and a wound contact layer (24). Figure 2b In FIG, the wound contact layer is shown as a perforated wound contact layer ( 24 ′).

[0082] Figure 3 A comparison of exemplary temperature profiles along a production line is shown, showing the temperature profile of a foam on a substrate (here: a fiber web) according to a conventional process (without accelerated curing) and according to an exemplary process of the present invention using radiant heating with six IR lamps (as a function of the temperature profile along the production line). Figure 1 function of position on the line shown); a temperature "spike" is evident, but once the IR heating is removed the temperature essentially returns to "normal". DETAILED DESCRIPTION

[0083] In the further description that follows, detailed embodiments of the present invention are described with reference to the accompanying drawings, which are illustrative illustrations of embodiments of the present invention.

[0084] Chemical:

[0085] In an embodiment of the present invention, the prepolymer is or comprises an isocyanate-terminated polyol or an isocyanate-terminated polyurethane.

[0086] In an embodiment of the present invention, the prepolymer is derived from the reaction between a polyol and a diisocyanate compound, wherein the diisocyanate compound is selected from hexamethylene diisocyanate (HDI), toluene diisocyanate (TDI), methylene diphenyl diisocyanate (MDI) or isophorone diisocyanate (IPDI) or any mixture thereof.

[0087] In an embodiment of the present invention, the prepolymer is derived from the reaction between a polyol such as polyethylene glycol and hexamethylene diisocyanate (HDI). In an embodiment of the present invention, the prepolymer is or comprises a hexamethylene isocyanate-terminated polyol, preferably a hexamethylene isocyanate-terminated polyethylene glycol, or a hexamethylene isocyanate-terminated polyurethane.

[0088] In a preferred embodiment of the present invention, the prepolymer is derived from the reaction between a polyol and toluene diisocyanate (TDI). In an embodiment of the present invention, the prepolymer is or comprises a toluene isocyanate-terminated polyol, preferably a toluene isocyanate-terminated polyethylene glycol, or a toluene isocyanate-terminated polyurethane.

[0089] In an embodiment of the present invention, the prepolymer is derived from the reaction between a polyol and methylene diphenyl diisocyanate (MDI). In an embodiment of the present invention, the prepolymer is or comprises a methylene diphenyl isocyanate-terminated polyol, preferably a methylene diphenyl isocyanate-terminated polyethylene glycol, or a methylene diphenyl isocyanate-terminated polyurethane.

[0090] In an embodiment of the present invention, the polyol is selected from polyester polyols, polyacrylate polyols, polyurethane polyols, polycarbonate polyols, polyether polyols, polyester polyacrylate polyols, polyurethane polyacrylate polyols, polyurethane polyester polyols, polyurethane polyether polyols, polyurethane polycarbonate polyols and polyester polycarbonate polyols, etc., especially condensates of diols or optional triols and tetraols and dicarboxylic acids or optional tricarboxylic acids and tetracarboxylic acids or hydroxycarboxylic acids or lactones.

[0091] Exemplary suitable diols are ethylene glycol, butanediol, diethylene glycol, triethylene glycol, polyalkylene glycols (such as polyethylene glycol) and 1,2-propylene glycol, 1,3-propylene glycol, 1,3-butanediol, 1,4-butanediol, 1,6-hexanediol and isomers, neopentyl glycol or neopentyl glycol hydroxypivalate. In addition, polyols such as trimethylolpropane, glycerol, erythritol, pentaerythritol, trimethylolbenzene or trishydroxyethyl isocyanurate are also within the scope of the present invention.

[0092] In an embodiment of the present invention, the polyol is polyethylene glycol (polyethylene oxide).Thus, in an embodiment of the present invention, the prepolymer is or comprises isocyanate-terminated polyethylene glycol.

[0093] In an embodiment of the present invention, the content of the diisocyanate compound in the prepolymer reaction mixture of the diisocyanate compound and the polyol is at least 15% (w / w) (relative to the total weight of the diisocyanate and the polyol in the prepolymer reaction mixture). In an embodiment of the present invention, the content of the diisocyanate compound in the prepolymer reaction mixture of the diisocyanate compound and the polyol is 15-60%, preferably 20-50% (w / w).

[0094] Process conditions

[0095] In an embodiment of the present invention, the entire process is carried out in such a way that the foam layer is treated at least partially continuously, in particular in or during steps (ii), (iii) and (iv).

[0096] "At least partially continuous" is meant to exclude any merely batch or stationary process. In the above process steps, the foam layer is continuously conveyed along the production line at least during a portion of the processing time.

[0097] In an embodiment of the present invention, the overall process is (only) partially continuous, as a defined volume of starting material will ultimately produce a given number of foam rolls that can be stored and used for further conversion steps (e.g., coating with silicone and / or use as a layer in a wound pad, etc.).

[0098] In an embodiment of the present invention, the process of the present invention is associated with a temperature profile along the production line, wherein the highest overall temperature is achieved in the acceleration step (iv).

[0099] Final Product

[0100] In an embodiment of the present invention, the foam obtained after step (iv) or step (v) is an open-cell foam, in particular having at least 50% open cells, preferably at least 90% open cells. As used herein, the term "open cell" refers to the cell structure of the foam, wherein the cells in the open-cell cell structure are interconnected and form an interconnected network.

[0101] In an embodiment of the present invention, the foam produced after step (iv) or step (v) is an open cell foam having cells with an average size varying between 30 μm and 1000 μm.

[0102] According to the present invention, the term "average pore size" is understood to mean the (maximum) cross-sectional area of ​​the pores, with a spherical approximation of the pores being applied. The pore size is measured by image analysis of the foam cross section, wherein the image analysis method is based on ISO 13322-1:2014, and the cross-sectional area of ​​the pores is calculated accordingly.

[0103] In an embodiment of the present invention, the hydrophilic polyurethane foam layer produced by step (iv) or step (v) has a density of 60 to 180 kg / m3 measured according to standard method ISO 845:2006. 3 Open-cell porous hydrophilic foam.

[0104] In an embodiment of the present invention, the foam layer is an open-cell porous hydrophilic foam having a density of 60 to 180 kg / m 3 , preferably 100 to 150 kg / m 3 , measured according to standard method ISO 845:2006.

[0105] In an embodiment of the present invention, the foam produced by step (iv) or step (v) has a thickness of 500 μm to 20 mm, preferably 1 mm to 15 mm. In an embodiment of the present invention, the thickness of the foam layer is 1 mm to 12 mm. In an embodiment of the present invention, the thickness of the foam layer is 1 mm to 10 mm. In an embodiment of the present invention, the thickness of the foam layer is 1 mm to 8 mm. In an embodiment of the present invention, the thickness of the foam layer is 1 mm to 5 mm.

[0106] In an embodiment of the present invention, the polyurethane foam layer obtained from step (iv) or step (v) is hydrophilic.

[0107] According to the present invention, the term "hydrophilicity" is understood as defined in the IUPAC: Compendium of Chemical Terminology, 2nd ed. ("Gold Book"), compiled by AD McNaught and A. Wilkinson. Blackwell Scientific Publications, Oxford (1997), ISBN 0-9678550-9-8, and generally refers to the ability of a molecular entity or substituent to interact with polar solvents, in particular water or other polar groups.

[0108] Preferably, the term "hydrophilic" refers to the water permeability of a material or the water absorption of a molecule. In the case of a material having pores (here an open-cell foam) or a material having through pores, a material is "hydrophilic" if it absorbs water.

[0109] In an embodiment of the present invention, the foam material is characterized by a free expansion absorption capacity, corresponding to the maximum absorption capacity measured in accordance with EN 13726-1:2002, of 800 to 2500 kg / m 3 .

[0110] In an embodiment of the present invention, the polyurethane foam layer produced by step (iv) or step (v) has an absorption rate of at least 5 μl / sec, preferably at least 10 μl / sec, more preferably at least 20 μl / sec.

[0111] Other foam components (antibacterial)

[0112] In an embodiment of the present invention, the foam layer comprises an antimicrobial agent. In an embodiment of the present invention, the antimicrobial agent comprises silver. In an embodiment of the present invention, the silver is metallic silver. In an embodiment of the present invention, the silver is a silver salt. In an embodiment of the present invention, the silver salt is silver sulfate, silver chloride, silver nitrate, silver sulfadiazine, silver carbonate, silver phosphate, silver lactate, silver bromide, silver acetate, silver citrate, CMC silver, or silver oxide. In an embodiment of the present invention, the silver salt is silver sulfate. In an embodiment of the present invention, the antimicrobial agent comprises a monoguanidine or a biguanide. In an embodiment of the present invention, the monoguanidine or biguanide is chlorhexidine digluconate, chlorhexidine diacetate, chlorhexidine dihydrochloride, polyhexamethylene biguanide (PHMB) or a salt thereof, or polyhexamethylene monoguanide (PHMG) or a salt thereof. In an embodiment of the present invention, the biguanide is PHMB or a salt thereof. In an embodiment of the present invention, the antimicrobial agent comprises a quaternary ammonium compound. In an embodiment of the present invention, the quaternary ammonium compound is cetylpyridinium chloride, benzethonium chloride, or poly-DADMAC. In an embodiment of the present invention, the antimicrobial agent comprises triclosan, sodium hypochlorite, copper, hydrogen peroxide, xylitol or honey.The advantages of the present invention have been demonstrated in the following examples.

[0113] Example

[0114] Foam layers according to embodiments of the present invention were prepared under standard laboratory conditions (at room temperature unless otherwise stated).

[0115] The foam layer was prepared by the following steps: (1) mixing a mixture containing a surfactant and a commercially available The aqueous phase of the prepolymer is metered into a mixer; (2) the aqueous solution and prepolymer are mixed in a pin mixer and distributed between two substrate layers; (3) the emulsion mixture is then molded to a certain thickness and width; (4) the foam is allowed to cure freely on a moving conveyor running at a fixed line speed; (5) after approximately four minutes, the reactive foam emulsion is heated with an IR heater (through the substrate layer) for approximately 0.5 minutes (24 seconds); (6) the fiber web (substrate) is then moved to the end of the conveyor belt, where the substrate is removed and the foam is exposed to a drying step; in step (7), the finished foam is collected into rolls and sampled.

[0116] This method according to an exemplary embodiment of the present invention can achieve approximately 25% faster curing times than the same or similar process without the IR heater.The process time advantage is achieved while little to no impact on foam properties is observed.

Claims

1. A process for producing a polyurethane foam layer, the process comprising at least the following steps: (i) at least one mixing step in which one or more polyurethane prepolymers or precursors thereof are mixed with each other or with another component suitable for use in a medical dressing in a mixing zone; (ii) at least one layer forming step, wherein the mixture from step (i) is applied to a moving substrate to form a layer and the curing process is initiated on the substrate; (iii) at least one conveying step, in which the foamed layer on the substrate from step (ii) is at least partially moved along the production line, in which step the polyurethane prepolymer or its precursor in the foamed layer is at least partially cured and the thickness of the layer increases due to foaming, i.e. due to at least one chemical reaction taking place in the layer; (iv) at least one accelerated curing step, which occurs at a predetermined point in time after the completion of step (ii) and correspondingly at a predetermined location along the production line, wherein curing is accelerated by subjecting the foam moving on the substrate to radiant heating; wherein (A) when the thickness of the foam increases by at least 60% relative to the thickness of the layer initially applied in step (ii), or (B) When the peak temperature of foam curing is reached, or (C) after the temperature at the start of step (iii) is in the range of 18°C ​​to 24°C, when the temperature of the foam layer is in the range of 25°C to 35°C, The predetermined time point in step (iv) is reached.

2. The process according to claim 1, wherein the radiant heating in step (iv) is infrared radiation.

3. The process according to claim 1, wherein (A) when the thickness of the foam increases by at least 80% relative to the thickness of the layer initially applied in step (ii), or (B) When the peak temperature has passed, or (C) after the temperature at the start of step (iii) is in the range of 18°C ​​to 23°C, when the temperature of the foam layer is in the range of 27°C to 32°C, The predetermined time point in step (iv) is reached.

4. The process according to claim 1 , wherein the process comprises at least a further step (v) performed after step (iv): (v) separate from and subsequent to step (iv): at least one drying step during which the substantially cured wet foam from step (iv) is dried to a predetermined lower moisture content.

5. The process according to any one of claims 1 to 4, wherein the polyurethane prepolymer is derived from the reaction between a polyol and a diisocyanate compound selected from hexamethylene diisocyanate (HDI), toluene diisocyanate (TDI), methylene diphenyl diisocyanate (MDI) or isophorone diisocyanate (IPDI) or any mixture thereof.

6. The process according to claim 5, wherein the diisocyanate compound is selected from toluene diisocyanate (TDI).

7. The process of claim 5, wherein the polyol is selected from the group consisting of polyester polyols, polyacrylate polyols, polyurethane polyols, polycarbonate polyols, polyether polyols, polyester polyacrylate polyols, polyurethane polyacrylate polyols, polyurethane polyester polyols, polyurethane polyether polyols, polyurethane polycarbonate polyols, and polyester polycarbonate polyols.

8. The process according to claim 7, wherein the polyol is selected from the group consisting of polycondensates of diols or optionally triols and tetraols and dicarboxylic acids or optionally tricarboxylic acids and tetracarboxylic acids or hydroxycarboxylic acids or lactones.

9. The process of any one of claims 1 to 4, wherein the polyurethane prepolymer comprises an isocyanate-terminated polyol or an isocyanate-terminated polyurethane.

10. The process of claim 9, wherein the polyurethane prepolymer is an isocyanate-terminated polyol or an isocyanate-terminated polyurethane.

11. The process according to any one of claims 1 to 4, wherein the foam layer applied to the substrate, ie the foam layer at the start of step (ii), has an initial thickness of 100 μm to 8 mm.

12. The process according to any one of claims 1 to 4, wherein the foam layer applied to the substrate, ie the foam layer at the start of step (ii), has an initial thickness of 250 μm to 2 mm.

13. A process according to any one of claims 1 to 4, wherein the predetermined time point in step (iv) is reached 2 to 10 minutes after the start of step (iii), or The predetermined point in time in step (iv) is reached once a given volumetric section of the foam layer has reached a degree of cure of 50% to 90%.

14. The process according to any one of claims 1 to 4, wherein the predetermined time point in step (iv) is reached 3 to 7 minutes after the start of step (iii), or The predetermined time point in step (iv) is reached once a given volume segment of the foam layer reaches a degree of cure of 65% to 85%.

15. A process according to any one of claims 1 to 4, wherein the predetermined position along the production line in step (iv) is 5 m or more from the point in the production line where the mixture from step (i) is applied to the substrate.

16. A process according to any one of claims 1 to 4, wherein the predetermined position along the production line in step (iv) is 10 m or more from the point in the production line where the mixture from step (i) is applied to the substrate.

17. A process according to any one of claims 1 to 4, wherein the predetermined position along the production line in step (iv) is 20 m or more from the point in the production line where the mixture from step (i) is applied to the substrate.

18. The process according to any one of claims 1 to 4, wherein the maximum temperature reached by the accelerated curing of step (iv) is controlled in the range of 30°C to 95°C.

19. The process according to any one of claims 1 to 4, wherein the maximum temperature reached by the accelerated curing of step (iv) is controlled to be in the range of 45°C to 90°C.

20. The process of claim 4, wherein the maximum temperature or average temperature in the drying step (v) is lower than the temperature in the accelerated curing step (iv).

21. The process of claim 4, wherein both the maximum temperature and the average temperature in the drying step (v) are lower than the temperature in the accelerated curing step (iv).

22. A process according to any one of claims 1 to 4, wherein the foam produced after step (iv) or step (v) is an open cell foam.

23. A process according to any one of claims 1 to 4, wherein the accelerated curing of step (iv) is achieved by infrared heating using 2 or more infrared lamps.

24. A process according to claim 23, wherein the accelerated curing of step (iv) is achieved by infrared heating using 4 or more infrared lamps.

25. The process of claim 23 wherein the lamps are spaced 20 cm to 2 m apart.

26. The process of claim 23 wherein the lamps are spaced 40 cm to 100 cm apart.

27. A medical dressing comprising a foam layer obtained or obtainable according to any one of claims 1 to 26.

28. The medical dressing of claim 27, wherein the medical dressing further comprises at least one additional layer.

29. The medical dressing of claim 28, wherein the medical dressing further comprises at least one backing layer.

30. The medical dressing of claim 28, wherein the medical dressing further comprises at least one adhesive layer or coating.